Background: Chalazia are common eyelid lesions in children, resulting from chronic inflammation of sebaceous glands. Management strategies vary, but evidence specific to pediatric populations is limited. Objectives: To review current evidence on treatment modalities for chalazia in children and propose a management algorithm. Methods: A comprehensive literature review was conducted, synthesizing data on conservative, medical, and surgical approaches to pediatric chalazia management. Results: Conservative treatments (warm compresses, lid hygiene) remain first-line, though pediatric-specific efficacy data is sparse. Topical antibiotics and steroids show mixed results, with potential adverse effects in children. Emerging therapies (probiotics, omega-3 supplementation, intense pulsed light) show promise but require further investigation. Intralesional steroid injections demonstrate high success rates but carry risks of rare complications. Surgical excision remains effective for persistent lesions. Tailored approaches considering underlying conditions (vitamin A deficiency, Demodex infestation, rosacea) are recommended. Conclusions: Management of pediatric chalazia lacks standardized protocols. A tailored approach balancing efficacy and safety is crucial. Large-scale, pediatric-focused studies are needed to establish evidence-based guidelines.
Purpose: To elicit, from a survey of oculoplastic surgeons, the timing and reason for delaying Jones tube placement after the excision of nasal or lacrimal drainage system malignancy. Methods: The authors reviewed current literature and distributed an anonymous survey to 627 members of the American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS) to determine the length of time members wait to perform a Jones tube placement after the removal of nasal or lacrimal drainage system malignancy. The survey also included questions about the rationale for this waiting period. Results: Fifty-eight members of ASOPRS (9.3%) responded to our survey, 49 (84.4%) of whom had performed Jones tube placement on patients who had an excision of a nasal or lacrimal drainage system malignancy. Nearly 52% of respondents waited one year for Jones tube placement. However, a sizeable number of respondents opted to wait five years (15.1%). The most common rationale for waiting was a concern for tumor recurrence (42 responses). Conclusion: There is no consensus on when to perform Jones tube placement after the excision of nasal or lacrimal drainage system malignancy. This survey demonstrates a broad array of waiting periods between operations, although most surgeons wait 12 months.
Background: Temozolomide (TMZ) is an effective oral alkylating agent used in treating glioblastoma multiforme (GBM) and high-grade gliomas. It works by introducing methyl groups into DNA, inhibiting cell division. A case of blepharoconjunctivitis linked to the administration of TMZ is detailed in this report. Case presentation: We present a case of a 58-year-old African-American man diagnosed with GBM. Following adjuvant TMZ treatment, he developed blepharoconjunctivitis, characterized by eyelid and conjunctival inflammation. Symptoms included eyelid swelling, crusting, and conjunctival discharge, which were promptly resolved with topical steroid cream and eye drops. Conclusions: Reports specifically linking TMZ to blepharoconjunctivitis are limited. The exact mechanism remains unclear but may involve inflammation extending from blepharitis to the conjunctiva. Healthcare providers must recognize and manage ophthalmic complications promptly. This case report highlights blepharoconjunctivitis associated with TMZ use in a GBM patient. While TMZ is an effective treatment, ophthalmic side effects can occur.
25 January 2017 in European Journal of Ophthalmology
Purpose: To describe a simple and novel technique of obtaining an extraocular muscle (EOM) biopsy. Methods: Our sutureless method involves obtaining a full-thickness 3-mm EOM specimen using a disposable punch biopsy. Results: The procedure was performed successfully, with no worsening of eye movement, muscle weakness, or cosmetic defects postoperatively. The acquired full-thickness specimen was sufficient for analysis. Conclusions: This technique to obtain an EOM biopsy allows a straightforward sutureless method, providing an adequate sample for tissue scrutiny.